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Introduction. Diseases caused by fungi affect millions of people every year worldwide 
and most of these infections requiring hospitalization and advanced treatment. There-
fore, well-timed and appropriate laboratory diagnostic, treatment of invasive fungal 
infections (IFIs) are major importance in the management of these diseases. The ana-
lyzed scientific studies highlighted that despite the drug availability on the market 
aimed to treat these infections, their efficiency is arguable, while their side effects can-
not be significant. As for the drawbacks of the available drugs, these are related to their 
physical-chemical properties Antifungal medicine is usually of hydrophobic character 
meaning they have poor solubility in water. Both issues lead to limitations in terms of 
their efficacy and efficiency within the clinical settings. Therefore, scientific studies on 
development of new antifungal compounds are urgently required. The purpose of the 
study was to carry out an analysis of the specialized literature related to nanotechnology 
approaches for fungal diseases, a new emerging novelty in treatment of IFIs. 
Material and methods. The study is based on 45 literature sources written by foreign 
authors (from USA, Italy, Germany, Canada, Spain, Romania etc.). Most publications 
come from highly developed countries. The bibliographic search was performed on the 
evidence-based sources, on the mostly relevant databases – such as PubMed, HINARI, 
Google Scholar. The filter for the publication date has been set for the last 10 years.  
Results. Over the recent decades, a specific scientific interest was given to nanotechnol-
ogy, which has become an extremely well-known and researched domain. The high inci-
dence of fungal infections has become a worrisome public health issue. The major issue 
among these is the resistance to antifungals, an increasing hazard for the effective 
treatment of IFI, which make therapy difficult sometimes even impossible. Late diagno-
sis and delayed treatment are the top causes for the high morbidity and mortality rates 
of IFIs. A number of studies reported challenges in using antifungals including but not 
limited to diminished efficacy of medication, limited drug penetration through tissue, 
low solubility in water, decreased bioavailability, and poor drug pharmacokinetic prop-
erties. Apart from the physical-chemical limitations, the low number of available anti-
fungal agents is also accompanied by their toxicity and high resistance.  
Currently, the treatment approach for IFIs is rather limited and includes three main 
classes of drugs, such as polyenes, azoles, and echinocandins. 
Considering that there is a stringent need for alternatives in treatment of invasive fungal 
infections, it is believed that nanostructured systems are the solution, since they could 
be excellent carriers for antifungal drugs. Studies that investigated the innovative thera-
peutic techniques via nanotechnology and medically important fungi have established 
that there are compelling enhancements in the antifungal properties, such as bioavaila-
bility, toxicity, and target tissue for some antifungal drugs.  
Conclusions. In conclusion, there is an obvious requirement for new therapeutic alter-
natives for IFIs due to the low number of drugs and their high resistance to antifungal 
agents, mainly in medically relevant fungi. The well-timed and adequate pathogen detec-
tion is decisive for disease management and prevention of drug resistance, thus aiding in 
the prevention of therapeutic failures and death in case of invasive fungal infections. 
There is an urgent need for cutting-edge and cost-effective nanotechnologies providing 
management of fungal diseases, which are considered challenging issues facing today’s 
health systems. 
 
